Detailed Product Description

Anti-Allergic Probiotic (en-Lac) Health Food

Totally new natural trend probiotic therapies

Relieving asthma, urticaria, allergic rhinitis, allergic conjunctivitis and atopic dermatitis symptoms
1. Probiotic AAP-1 is being conducted phase 3 clinical trail
2. Probiotic AAP-1 was honored by Symbol of National Quality and National Biomedical      Product Silver Award (Innovational application of probiotics from human intestine for immunity pathways modulation to achieve balanced immune system)
3. China new food ingredient approvalLacbocillus paracasei GM-080
4. US, CN, and TW Patents:
    ∴US Patent US 6994848 B2
    ∴CN Patent02149825.3
    ∴TW Patent277651, 284149

GenMont functional probiotics adjust physiological performances safely and naturally
1. Regulates the intestine permeability and balances the ecology of intestinal bacterial flora.
2. Improves immunity along the intestine linings.

3. Alleviates inflammatory reactions in the intestines.
4. Reduces local/systematic allergic reactions and the subsequent cytokine production.

AAP-1 has the features listed below:

1. A study demonstrating AAP-1 is potent in treating allergy has been published in a renowned academic journal, Pediatr Allergy Immunology 2004:15: pp.152-158 and 2005: 16: pp.433438.
2. Clinical studies conducted by China Medical University showed that AAP-1 can effectively alleviate allergic symptoms and improve allergic reactions. Natural and safe: AAP-1 is derived from local bacteria strain, which is more suitable for people in Taiwan.
3. AAP-1 can regulate immunological responses by shifting the reactions toward the non-inflammatory Th1 pathway.

Potential commercial applications:
    a. Form: bacteria powder/solution
    b. AAP-1 can be added into fermentation products, snacks, milk (fresh/powder)and cosmetics to enhance the nutrition values

Features:
    a. Resistant to gastric acid and bile; high adherence to intestinal wall
    b. Continuous use for 1 month can reduce allergic symptoms by 40~50%
    c. Continuous use for 3 months can reduce IgE level by 20~25%
    d. Continuous use for 6 months can reduce the risk of allergy recurrences
    e. Generally recognized as safe (GRAS) lactic acid bacterial strain is used for production.    No adverse effects upon consumption.

Targeted users:
    a. Allergy patients (asthma, allergic rhinitis, ectopic dermatitis, allergic conjunctivitis, urticaria, food allergy)
    b. Seasonal allergy patients
    c. Preventing fetal allergy: use AAP-1 during late pregnancy (7~9 month)
    d. Adjust neonatal allergy: continuous use of AAP-1 for 6 months can prevent infants from developing allergies by 50%